Latest Breaking News On - Amir reichman - Page 3 : comparemela.com

Scinai (NASDAQ: SCNI) to Host Analyst and Investor Webinar on January 9 -December 27, 2023 at 07:16 am EST

JERUSALEM, Dec. 27, 2023 /PRNewswire/ Scinai Immunotherapeutics Ltd. , a biopharmaceutical company focused both on development of inflammation and immunology biological products and provision of.

Israel generalScinai immunotherapeuticsAmir reichmanJoshua phillipsonCompany contactExchange commissionPrnewswire scinai immunotherapeutics ltdScinai immunotherapeutics ltdEuropean investment bankCompany annual report on formPrivate litigation reform actAnnual report

Scinai (NASDAQ: SCNI) To Host Analyst And Investor Webinar On January 9

Scinai (NASDAQ: SCNI) To Host Analyst And Investor Webinar On January 9
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Israel generalScinai immunotherapeuticsAmir reichmanJoshua phillipsonPrnewswire scinai immunotherapeutics ltdCompany contactEuropean investment bankScinai immunotherapeutics ltdExchange commissionCompany annual report on formPrivate litigation reform actAnnual report

BioMedNewsBreaks – Scinai Immunotherapeutics Ltd (NASDAQ: SCNI) Announces January Analyst, Investor Webinar

BioMedNewsBreaks – Scinai Immunotherapeutics Ltd (NASDAQ: SCNI) Announces January Analyst, Investor Webinar
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesAmir reichmanScinai immunotherapeuticsBiomedical sciences biomedScinai immunotherapeutics ltdLife sciencesBiomedical sciencesDynamic brand portfolioPhones only

Study published in Antiviral Research supports promise of Scinai Immunotherapeutics coronavirus NanoAb as aerosolized prophylactic and therapeutic drug

Data backs use of Scinai s aerosolized NanoAbs as a platform for the treatment of hyperinflammatory viral diseases, addressing significant medical needs JERUSALEM, Dec. 11, 2023 /PRNewswire/.

Israel generalScinai nanoabsMatthias dobbelsteinJoshua phillipsonAmir reichmanMax planckScinai immunotherapeuticsTamar ben yedidiaScinai bioservicesScinai immunotherapeutics ltdMax planck societyExchange commissionCompany annual report on formIsraeli innovation authorityUniversity medical centerCompany contact

European Investment Bank (EIB) extends maturity of its finance facility with Scinai Immunotherapeutics from 2027 to 2031

/PRNewswire/ Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) announced today the execution of a formal amendment to its finance contract with the European.

Israel generalJoshua phillipsonAmir reichmanScinai bioserviceScinai immunotherapeuticsCompany contactEuropean unionPrnewswire scinai immunotherapeutics ltdScinai immunotherapeutics ltdEuropean investment bankListing ruleScinai immunotherapeutics ltd